Nuzenio
Source-attributed brief
Lilly launches cancer therapy Tanstrive for patients with advanced or metastatic solid tumors with a RET gene alteration
Twice a day oral drug is priced at ₹2.15 lakh for two weeks treatment
AI summary
Twice a day oral drug is priced at ₹2.15 lakh for two weeks treatment
What happened
Twice a day oral drug is priced at ₹2.15 lakh for two weeks treatment
Why it matters
This business report is being tracked from The Hindu BusinessLine because it may affect readers, markets, policy, culture, or daily decisions.
Key facts
- Category: business
- Edition: IN
- Fetched: Thu, 25 Jun 2026 18:32:05 GMT
Nuzenio shows copyright-safe summaries and context. Full reporting stays with the original publisher.